These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Adherence to statins: updates and practical proposals]. Bauwens M; Schneider MP; Nanchen D Rev Med Suisse; 2016 Mar; 12(508):445-8, 450. PubMed ID: 27089601 [TBL] [Abstract][Full Text] [Related]
24. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Gotto AM; Farmer JA Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M; Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022 [TBL] [Abstract][Full Text] [Related]
26. The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pate A; Elliott RA; Gkountouras G; Thompson A; Emsley R; van Staa T Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):644-652. PubMed ID: 32394495 [TBL] [Abstract][Full Text] [Related]
27. Risk of diabetes with statins must be monitored in each patient. Bifulco M BMJ; 2013 Jul; 347():f4170. PubMed ID: 23820519 [No Abstract] [Full Text] [Related]
28. Addressing statin adverse effects in the clinic: the 5 Ms. Katz DH; Intwala SS; Stone NJ J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):533-42. PubMed ID: 24770611 [TBL] [Abstract][Full Text] [Related]
29. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy. Fazio S Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268 [TBL] [Abstract][Full Text] [Related]
30. MY APPROACH to the Patient With Memory Loss Who Needs a Statin. Watson KE; Sallam T Trends Cardiovasc Med; 2017 Feb; 27(2):158-159. PubMed ID: 28107839 [No Abstract] [Full Text] [Related]
31. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship? Shah PK Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083 [TBL] [Abstract][Full Text] [Related]
32. Questioning the benefits of statins. Vos E; Rose CP CMAJ; 2005 Nov; 173(10):1207; author reply 1210. PubMed ID: 16275976 [No Abstract] [Full Text] [Related]
33. Statins and the quality and outcomes framework. Taylor DG BMJ; 2013 Jul; 347():f4171. PubMed ID: 23820520 [No Abstract] [Full Text] [Related]
34. Muscle- and skeletal-related side-effects of statins: tip of the iceberg? Auer J; Sinzinger H; Franklin B; Berent R Eur J Prev Cardiol; 2016 Jan; 23(1):88-110. PubMed ID: 25230981 [TBL] [Abstract][Full Text] [Related]
36. Intermittent statin use may help with side effects. Mayo Clin Health Lett; 2014 Jul; 32(7):4. PubMed ID: 25178143 [No Abstract] [Full Text] [Related]
38. Statin potency associated with incident diabetes in a real-world evaluation. Steen DL; Bhatt DL Evid Based Med; 2014 Apr; 19(2):68. PubMed ID: 23990528 [No Abstract] [Full Text] [Related]
39. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy. Corrao G; Conti V; Merlino L; Catapano AL; Mancia G Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788 [TBL] [Abstract][Full Text] [Related]
40. Statin therapy in the elderly: a review. Szadkowska I; Stanczyk A; Aronow WS; Kowalski J; Pawlicki L; Ahmed A; Banach M Arch Gerontol Geriatr; 2010; 50(1):114-8. PubMed ID: 19217673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]